Which of the following is a complication of neonatal hyperbilirubinemia?

DSSSB - 28 August 2019 (Shift-1)

Child Health Nursing (Pediatrics)

Easy

Appeared in: DSSSB - 28 August 2019 (Shift-1)

Explanation

Kernicterus, also known as bilirubin encephalopathy, is a severe neurological complication of untreated or severe neonatal hyperbilirubinemia.
It occurs when high levels of unconjugated (indirect) bilirubin cross the blood-brain barrier and deposit in the brain tissue, particularly the basal ganglia and brainstem nuclei.
This deposition is neurotoxic and leads to permanent brain damage, resulting in conditions such as cerebral palsy, hearing loss, and developmental delays.
The signs of acute bilirubin encephalopathy include poor suck, lethargy, hypotonia, and seizures, which can progress to hypertonia and opisthotonos (arching of the back).

Option A: Hepatitis is an inflammation of the liver. While it can lead to jaundice (hyperbilirubinemia) because the inflamed liver cannot properly conjugate and excrete bilirubin, it is a potential cause of the condition, not a complication resulting from it.
Option B: Icterus is the medical term for jaundice, which is the yellowing of the skin and sclera. Jaundice is the primary clinical sign or symptom of hyperbilirubinemia itself, not a complication that develops from it.
Option D: Down syndrome is a chromosomal disorder (Trisomy 21) that is determined at conception. It is not caused by or related to the metabolic processes involving bilirubin after birth. While infants with Down syndrome may experience jaundice, it is not a complication of hyperbilirubinemia.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Complications of Neonatal Hyperbilirubinemia as background academic context rather than a clinical decision trigger.
The primary clinical goal in managing neonatal jaundice is to prevent kernicterus. Nurses play a crucial role in monitoring newborns for jaundice, assessing risk factors (e.g., prematurity, blood type incompatibility, breastfeeding difficulties), and ensuring timely bilirubin screening (transcutaneous or serum).
Early and effective treatment, primarily with phototherapy, is essential to reduce bilirubin levels before they reach a neurotoxic threshold. In severe cases, an exchange transfusion may be necessary.
What if? If a newborn develops jaundice within the first 24 hours of life, it is always considered pathologic, not physiologic. This requires immediate investigation for causes like hemolysis (e.g., ABO/Rh incompatibility) because the risk for rapid bilirubin rise and kernicterus is significantly higher.

How to Approach the Question

First, identify the core of the question: it asks for a 'complication' of neonatal hyperbilirubinemia.
Understand the difference between a sign/symptom, a cause, and a complication. A complication is a secondary problem that arises from a primary disease.
Evaluate Option A (Hepatitis): This is liver inflammation, which is a cause of jaundice, not a result of it.
Evaluate Option B (Icterus): This is another name for jaundice, the main sign of hyperbilirubinemia, not a complication.
Evaluate Option C (Kernicterus): This is a known, severe neurological condition caused by high bilirubin levels affecting the brain. This fits the definition of a complication.
Evaluate Option D (Down syndrome): This is a genetic condition and is unrelated. Therefore, it cannot be a complication.

Concept Tested & Keywords

QJ-VMHDMt5SkgUVCy2y0ym

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 p. 1121-1123